Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Appropriations funding for NIH, FDA, AHRQ; support for HR 2866 the Improving Access to Clinical Trials Act of 2009; health reform; HR 2965 Reauthorizing the Small Business Innovation and Research Act; Medical Foods Equity Act; home infusion guidance with CMS.
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2010 · first_quarter · 1A
Appropriations Funding for NIH, FDA, AHRQ; support for HR 2866, the Improving Access to Clinical Trials Act; health reform; HR 2965, Reauthorizing the Small Business Innovation and Research Act; Medical Foods Equity Act; Home Infusion Guidance from CMS
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Social Security Administration (SSA)
Source: Senate LDA
Appropriations Funding for NIH, FDA, AHRQ; support for HR 2866, the Improving Access to Clinical Trials Act; health reform; HR 2965, Reauthorizing the Small Business Innovation and Research Act; Medical Foods Equity Act; Home Infusion Guidance from CMS
Don't Ask, Don't Tell Repeal Act of 2010
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Appropriations funding for NIH, FDA, AHRQ; support for HR 2866 the Improving Access to Clinical Trials Act of 2009; health reform; HR 2965 Reauthorizing the Small Business Innovation and Research Act; Medical Foods Equity Act; home infusion guidance with CMS.
Don't Ask, Don't Tell Repeal Act of 2010
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Appropriations Funding for NIH, FDA, AHRQ; support for HR 2866, the Improving Access to Clinical Trials Act; health reform; HR 2965, Reauthorizing the Small Business Innovation and Research Act; Medical Foods Equity Act; Home Infusion Guidance from CMS
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Increased funding for NIH; Support for H.R. 2866, the Improving Access to Clinical Trials Act of 2009; Health Reform; H.R. 2965 Reauthorizing the Small Business Innovation and Research Act
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations
Don't Ask, Don't Tell Repeal Act of 2010
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Increased funding for NIH; Support for H.R. 2866, the Improving Access to Clinical Trials Act of 2009; Health Reform; H.R. 2965 Reauthorizing the Small Business Innovation and Research Act
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations
Improving Access to Clinical Trials Act of 2009
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Supporting the goals and ideals of National Cystic Fibrosis Awareness Month.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Access to health care, NIH funding, Social Security Administration's eligibility rules impact on clinical trials, Labor HHS appropriations, Small Business Innovation Research, H.Con.Res.299 - Cystic Fibrosis Awareness Resolution, S.Res.510 - Cystic Fibrosis Awareness Resolution
A resolution supporting the goals and ideals of National Cystic Fibrosis Awareness Month.
Client: CYSTIC FIBROSIS FOUNDATION · Firm: CYSTIC FIBROSIS FOUNDATION
Access to health care, NIH funding, Social Security Administration's eligibility rules impact on clinical trials, Labor HHS appropriations, Small Business Innovation Research, H.Con.Res.299 - Cystic Fibrosis Awareness Resolution, S.Res.510 - Cystic Fibrosis Awareness Resolution
2010 · first_quarter · Q1
Appropriations funding for NIH, FDA, AHRQ; support for HR 2866 the Improving Access to Clinical Trials Act of 2009; health reform; HR 2965 Reauthorizing the Small Business Innovation and Research Act; Medical Foods Equity Act; home infusion guidance with CMS.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · fourth_quarter · 4A
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · fourth_quarter · Q4
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · third_quarter · Q3
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations, UNOS - Organ Allocations, Federal funding for research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · first_quarter · 1A
stimulus package, Children's Health Insurance Program, increase in fudnign for NIH, health care research & quality, pharmacy waivers from CMS, FDA's denial of Gilead Sciences Aztreonam Lysine, Social Security Income rules, Small Business Innovation & Research program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · third_quarter · Q3
H.R. 2866 and S. 1674 "Improving Access to Clinical Trials Act of 2009," Appropriations/ NIH & AHRQ, health reform, organ allocations
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), President of the U.S., SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · second_quarter · Q2
Increased funding for NIH; Support for H.R. 2866, the Improving Access to Clinical Trials Act of 2009; Health Reform; H.R. 2965 Reauthorizing the Small Business Innovation and Research Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · first_quarter · Q1
stimulus package, Children's Health Insurance Program, increase in fudnign for NIH, health care research & quality, pharmacy waivers from CMS, FDA's denial of Gilead Sciences Aztreonam Lysine, Social Security Income rules, Small Business Innovation & Research program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2009 · first_quarter · Q1
Stimulus package, Children's Health Insurance Program, increase in funding for National Institutes of Health, health care research & quality, pharmacy waivers from CMS, FDA's denial of Gilead Sciences Aztreonam Lysine, Social Security Income rules, Small Business Innovation & Research program
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Small Business Administration (SBA), Social Security Administration (SSA), White House Office
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2008 · fourth_quarter · Q4
The CF Foundation includes the following in its 2008 lobbying activities: calling on Congress and the Executive branch to improve access to specialized care and a reduction in the high cost of medicine for CF patients, requests to increase public investment for drug and disease research particularly for the National Institutes of Health, requests for the Food & Drug Administration to reconsider the drug application Gilead Sciences submitted for Aztreonam Lysine for Inhalation (AZLI), requests to Congress to reauthorize the Small Business Innovation Research (SBIR) program, and requests to the Social Security Administration to change Social Security Income requirements.
Filing targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA), Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2008 · third_quarter · Q3
Social Security Income, Access to care issues, NIH funding
Small Business Research Innovation Research program
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2008 · second_quarter · Q2
Access to health care, NIH funding, Social Security Administration's eligibility rules impact on clinical trials, Labor HHS appropriations, Small Business Innovation Research, H.Con.Res.299 - Cystic Fibrosis Awareness Resolution, S.Res.510 - Cystic Fibrosis Awareness Resolution
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Social Security Administration (SSA)
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2008 · first_quarter · Q1
Small Business Innovation Research program, NIH, Newborn Screening, clinical trials funding, Social Security - Compassionate Allowance
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2007 · year_end · YA
SCHIP, Follow-on biologics, small business research grants, NIH Funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2007 · mid_year · MA
Newborn Screening, FDA reauthorization, SCHIP reauthorization, Follow-on biologics, Home Infusion
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2007 · year_end · YA
SCHIP, follow-on biologics, small business research grants, NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CYSTIC FIBROSIS FOUNDATION via CYSTIC FIBROSIS FOUNDATION
2007 · year_end · YY
SCHIP, follow-on biologics, small business research grants, NIH funding
Filing targets: HOUSE OF REPRESENTATIVES, SENATE